Talal Mohamad Amine El Zarif, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Epigenomics | 4 | 2024 | 943 | 1.300 |
Why?
|
Penile Neoplasms | 1 | 2023 | 161 | 0.790 |
Why?
|
Carcinoma, Renal Cell | 7 | 2024 | 3163 | 0.780 |
Why?
|
Kidney Neoplasms | 7 | 2024 | 4251 | 0.700 |
Why?
|
Measles-Mumps-Rubella Vaccine | 1 | 2020 | 71 | 0.670 |
Why?
|
Mumps | 1 | 2020 | 71 | 0.660 |
Why?
|
Head and Neck Neoplasms | 2 | 2024 | 2896 | 0.640 |
Why?
|
Telomerase | 1 | 2024 | 741 | 0.630 |
Why?
|
Measles | 1 | 2020 | 181 | 0.590 |
Why?
|
Lung Neoplasms | 5 | 2024 | 13382 | 0.440 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2023 | 2293 | 0.360 |
Why?
|
Disease Outbreaks | 1 | 2020 | 1747 | 0.350 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 3 | 2024 | 5318 | 0.350 |
Why?
|
Thyroid Neoplasms | 1 | 2024 | 2331 | 0.350 |
Why?
|
Vaccination | 2 | 2021 | 3368 | 0.310 |
Why?
|
Carcinoma, Squamous Cell | 1 | 2023 | 4021 | 0.300 |
Why?
|
Liver Neoplasms | 1 | 2023 | 4308 | 0.280 |
Why?
|
Receptors, Androgen | 2 | 2022 | 1077 | 0.260 |
Why?
|
Melanoma | 1 | 2024 | 5694 | 0.240 |
Why?
|
Mutation | 4 | 2024 | 30006 | 0.230 |
Why?
|
Phenylthiohydantoin | 1 | 2024 | 205 | 0.210 |
Why?
|
Paraneoplastic Syndromes | 1 | 2024 | 155 | 0.200 |
Why?
|
Nephrectomy | 2 | 2024 | 938 | 0.200 |
Why?
|
Proto-Oncogene Proteins c-fos | 1 | 2024 | 584 | 0.190 |
Why?
|
Carcinoma, Signet Ring Cell | 1 | 2021 | 82 | 0.190 |
Why?
|
Epigenesis, Genetic | 2 | 2024 | 3790 | 0.180 |
Why?
|
Morbillivirus | 1 | 2020 | 3 | 0.180 |
Why?
|
Mumps virus | 1 | 2020 | 23 | 0.180 |
Why?
|
Immunotherapy | 3 | 2024 | 4642 | 0.170 |
Why?
|
DNA Methylation | 2 | 2024 | 4386 | 0.170 |
Why?
|
Small Cell Lung Carcinoma | 1 | 2024 | 423 | 0.170 |
Why?
|
Lebanon | 1 | 2020 | 243 | 0.160 |
Why?
|
Nitriles | 1 | 2024 | 971 | 0.160 |
Why?
|
Benzamides | 1 | 2024 | 1370 | 0.160 |
Why?
|
Registries | 2 | 2024 | 8236 | 0.150 |
Why?
|
Drug Repositioning | 1 | 2020 | 233 | 0.150 |
Why?
|
Carcinoma, Lobular | 1 | 2021 | 480 | 0.140 |
Why?
|
Neoplasms | 5 | 2024 | 22125 | 0.140 |
Why?
|
Cadherins | 1 | 2021 | 902 | 0.140 |
Why?
|
HIV Infections | 1 | 2023 | 17349 | 0.130 |
Why?
|
Retrospective Studies | 9 | 2024 | 80673 | 0.130 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2024 | 2820 | 0.120 |
Why?
|
Male | 13 | 2024 | 360675 | 0.120 |
Why?
|
Germ-Line Mutation | 1 | 2021 | 1852 | 0.110 |
Why?
|
Neoplasm Metastasis | 1 | 2024 | 4908 | 0.110 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 2 | 2024 | 11732 | 0.110 |
Why?
|
Humans | 25 | 2024 | 761098 | 0.100 |
Why?
|
Promoter Regions, Genetic | 1 | 2024 | 5775 | 0.100 |
Why?
|
Neoplastic Stem Cells | 1 | 2020 | 1348 | 0.100 |
Why?
|
Refugees | 1 | 2020 | 595 | 0.100 |
Why?
|
Stomach Neoplasms | 1 | 2021 | 1458 | 0.090 |
Why?
|
Antigens, CD | 1 | 2021 | 4008 | 0.090 |
Why?
|
Middle Aged | 8 | 2024 | 220835 | 0.090 |
Why?
|
Female | 9 | 2024 | 392458 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2024 | 8529 | 0.080 |
Why?
|
Cell Differentiation | 1 | 2024 | 11505 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2023 | 10203 | 0.060 |
Why?
|
Glioma | 1 | 2020 | 3452 | 0.060 |
Why?
|
Aged | 7 | 2024 | 169266 | 0.060 |
Why?
|
Hospitalization | 1 | 2024 | 10712 | 0.060 |
Why?
|
Purine-Nucleoside Phosphorylase | 1 | 2023 | 28 | 0.060 |
Why?
|
Genome-Wide Association Study | 1 | 2022 | 12670 | 0.050 |
Why?
|
Protein-Arginine N-Methyltransferases | 1 | 2023 | 127 | 0.050 |
Why?
|
Interleukin-7 | 1 | 2022 | 143 | 0.050 |
Why?
|
Colorectal Neoplasms | 1 | 2021 | 6919 | 0.050 |
Why?
|
Prostatic Neoplasms | 1 | 2022 | 11103 | 0.040 |
Why?
|
Prednisone | 1 | 2024 | 1565 | 0.040 |
Why?
|
Germ Cells | 1 | 2022 | 632 | 0.040 |
Why?
|
Brain Neoplasms | 1 | 2020 | 9025 | 0.040 |
Why?
|
Infant | 1 | 2020 | 36164 | 0.040 |
Why?
|
Mice | 1 | 2024 | 81324 | 0.040 |
Why?
|
Child, Preschool | 1 | 2020 | 42217 | 0.040 |
Why?
|
Oncogenes | 1 | 2023 | 1220 | 0.030 |
Why?
|
Young Adult | 2 | 2021 | 59199 | 0.030 |
Why?
|
Tumor Burden | 1 | 2022 | 1892 | 0.030 |
Why?
|
Immunity | 1 | 2022 | 996 | 0.030 |
Why?
|
Forkhead Transcription Factors | 1 | 2023 | 1612 | 0.030 |
Why?
|
Adult | 4 | 2024 | 221083 | 0.030 |
Why?
|
Child | 2 | 2020 | 80134 | 0.030 |
Why?
|
Breast Neoplasms | 1 | 2021 | 20981 | 0.030 |
Why?
|
Lipid Metabolism | 1 | 2022 | 1893 | 0.030 |
Why?
|
Androgen Antagonists | 1 | 2022 | 1408 | 0.030 |
Why?
|
Up-Regulation | 1 | 2022 | 4111 | 0.030 |
Why?
|
Kaplan-Meier Estimate | 1 | 2024 | 6482 | 0.030 |
Why?
|
Treatment Outcome | 3 | 2024 | 64670 | 0.030 |
Why?
|
Respiration, Artificial | 1 | 2024 | 2630 | 0.030 |
Why?
|
Molecular Targeted Therapy | 1 | 2024 | 2813 | 0.030 |
Why?
|
Animals | 1 | 2024 | 168083 | 0.030 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2023 | 3493 | 0.030 |
Why?
|
Pandemics | 2 | 2022 | 8663 | 0.020 |
Why?
|
Adolescent | 1 | 2020 | 88271 | 0.020 |
Why?
|
Testosterone | 1 | 2022 | 2472 | 0.020 |
Why?
|
Sequence Analysis, DNA | 1 | 2021 | 4739 | 0.020 |
Why?
|
Medical Oncology | 1 | 2022 | 2316 | 0.020 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2021 | 3634 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2024 | 58946 | 0.020 |
Why?
|
Databases, Factual | 1 | 2024 | 7969 | 0.020 |
Why?
|
Prospective Studies | 2 | 2022 | 54419 | 0.020 |
Why?
|
Severity of Illness Index | 1 | 2024 | 15845 | 0.020 |
Why?
|
Cognition | 1 | 2022 | 6987 | 0.020 |
Why?
|
Pediatrics | 1 | 2020 | 3589 | 0.010 |
Why?
|
Prevalence | 1 | 2021 | 15717 | 0.010 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2022 | 9278 | 0.010 |
Why?
|
Transcription Factors | 1 | 2023 | 12096 | 0.010 |
Why?
|
Genetic Predisposition to Disease | 1 | 2021 | 17889 | 0.010 |
Why?
|
Antineoplastic Agents | 1 | 2020 | 13630 | 0.010 |
Why?
|